How Long Is Clinical Research Valuable for?

Value of information methods provide an approach to quantify the expected value of resolving uncertainty in a decision. It provides a quantitative basis to assess the expected value of clinical research projects and to understand the health impact of granting accelerated access to innovative medicines with uncertain benefits. Information generated from a clinical trial can be used to inform decisions for patients in the present and in the future. This means that when estimating the expected value of research we must make a judgment about how long the research will be valuable for, which we define as T. Despite its large impact on results, there is scant research, theoretical or empirical, to inform this judgment. We provide a general approach to estimating T reflecting treatment entry and price changes. In our case study we find T ranges between 13 years and infinity. The specific value depends on the type of parameter (whether it is treatment specific or not), the rate of innovation in the indication of interest and the magnitude of price reduction associated with generic entry. For the first time, this provides a method and starting point for analysts to justify the choice of T in applied contexts.

Authors

Institutions

Publication Details

Journal
Health Economics
Published
2026-11-18
DOI
https://doi.org/10.1002/hec.70178
Primary Topic
Health Systems, Economic Evaluations, Quality of Life
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

How Long Is Clinical Research Valuable for?

David Glynn, Sabine Elisabeth Grimm, Annabel Louisa Davies, Roje Layne
Health Economics
Health Systems, Economic Evaluations, Quality of Life
article

How Long Is Clinical Research Valuable for?

David Glynn, Sabine Elisabeth Grimm, Annabel Louisa Davies, Roje Layne
article en

Abstract

Value of information methods provide an approach to quantify the expected value of resolving uncertainty in a decision. It provides a quantitative basis to assess the expected value of clinical research projects and to understand the health impact of granting accelerated access to innovative medicines with uncertain benefits. Information generated from a clinical trial can be used to inform decisions for patients in the present and in the future. This means that when estimating the expected value of research we must make a judgment about how long the research will be valuable for, which we define as T. Despite its large impact on results, there is scant research, theoretical or empirical, to inform this judgment. We provide a general approach to estimating T reflecting treatment entry and price changes. In our case study we find T ranges between 13 years and infinity. The specific value depends on the type of parameter (whether it is treatment specific or not), the rate of innovation in the indication of interest and the magnitude of price reduction associated with generic entry. For the first time, this provides a method and starting point for analysts to justify the choice of T in applied contexts.

Health Economics
Ollscoil na Gaillimhe – University of Galway (IE), Maastricht University Medical Centre (NL), Maastricht University (NL), University of Bristol (GB), Care and Public Health Research Institute (NL), University of York (GB)
Health Systems, Economic Evaluations, Quality of Life
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon